Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - isoptin tablets 80mg (immediate release) are indicated for: hypertension; angina of effort; angina at rest; vasospastic angina (including prinzmetal's variant angina); tachyarrhythmias including paroxysmal supra-ventricular tachycardia; atrial fibrillation with rapid ventricular response; atrial flutter with rapid ventricular response.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - isoptin tablets 40mg (immediate release) are indicated for: hypertension; angina of effort; angina at rest; vasospastic angina (including prinzmetal's variant angina); tachyarrhythmias including paroxysmal supra-ventricular tachycardia; atrial fibrillation with rapid ventricular response; atrial flutter with rapid ventricular response.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 240 mg - tablet, film coated - excipient ingredients: sodium alginate; powdered cellulose; purified water; magnesium stearate; hypromellose; purified talc; titanium dioxide; povidone; macrogol 400; macrogol 6000; quinoline yellow; indigo carmine; glycol/butylene glycol montanate - isoptin sr (verapamil hydrochloride) is indicated for the management of essential hypertension and angina pectoris.

United States - English - NLM (National Library of Medicine)

ranbaxy laboratories inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - tablet, coated - 120 mg - isoptin sr (verapamil hci) is indicated for the management of essential hypertension. verapamil hci is contraindicated in: 1. severe left ventricular dysfunction (see warnings) 2. hypotension (systolic pressure less than 90 mmhg) or cardiogenic shock 3. sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) 4. second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). 5. patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings). 6. patients with known hypersensitivity to verapamil hydrochloride.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - indications as at 22 september 1995 : the management of hypertension. isoptin sr (verapamil hydrochloride) is indicated for the treatment of hypertension and angina pectoris.,isoptin sr (verapamil hydrochloride) is indicated for the management of hypertension and angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 5 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - indications as at 17 jan 2005 : tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.,tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation with rapid ventricular response, (except in wpw syndrome, see "precautions"), atrial flutter with rapid conduction, extrasystoles. for the prophylaxis and/or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia, respectively. acute hypertension. acute coronary insufficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - verapamil hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - verapamil hydrochloride -

Malta - English - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - solution for injection/infusion - verapamil hydrochloride 2.5 mg - calcium channel blockers

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - film coated tablet - 80 milligram